Friis H, Andreasen P B
Medical Department F. Gentofte Hospital, Hellerup, Denmark.
J Intern Med. 1992 Aug;232(2):133-8. doi: 10.1111/j.1365-2796.1992.tb00562.x.
The Danish Committee on Adverse Drug Reactions received 1100 reports of suspected drug-induced hepatic injury during the decade 1978-1987. The causal relationship between drug and hepatic injury was classified as definite in 57 (5.2%) reports, probable in 989 (89.9%) reports, possible in 50 (4.5%) reports and unclassifiable in four (0.4%) reports. Hepatic injuries accounted for 5.9% of all adverse drug reactions reported, and 14.7% of the lethal adverse drug reactions. A total of 47.2% were classified as acute cytotoxic, 16.2% as acute cholestatic and 26.9% as abnormal hepatic function. In 52 (4.7%) cases the hepatic injury was lethal; only 14 (1.3%) cases were chronic. Halothane accounted for 25% of the cases. The incidence of halothane-induced hepatic injury is decreasing, and only one lethal case has been reported since 1981. Next to halothane, sulfasalazine was the drug most often suspected during the last 2 years of the decade. Based on consumption data, the incidence of hepatic injury due to sulindac was estimated to be 18-fold higher than that due to ibuprofen. Paracetamol was reported to induce acute cytotoxic as well as cholestatic reactions in non-alcoholic subjects taking therapeutic doses.
丹麦药物不良反应委员会在1978年至1987年的十年间收到了1100份疑似药物性肝损伤的报告。药物与肝损伤之间的因果关系在57份(5.2%)报告中被分类为肯定,在989份(89.9%)报告中为很可能,在50份(4.5%)报告中为可能,在4份(0.4%)报告中无法分类。肝损伤占所有报告的药物不良反应的5.9%,占致命药物不良反应的14.7%。总共47.2%被分类为急性细胞毒性,16.2%为急性胆汁淤积性,26.9%为肝功能异常。在52例(4.7%)病例中,肝损伤是致命的;只有14例(1.3%)是慢性的。氟烷占病例的25%。氟烷性肝损伤的发生率正在下降,自1981年以来仅报告了1例致命病例。在这十年的最后两年中,除氟烷外,柳氮磺胺吡啶是最常被怀疑的药物。根据消费数据,舒林酸所致肝损伤的发生率估计比布洛芬所致肝损伤的发生率高18倍。据报道,对乙酰氨基酚在服用治疗剂量的非酒精性受试者中可引起急性细胞毒性以及胆汁淤积反应。